)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Active Biotech
Active Biotech (ACTI) investor relations material
Active Biotech Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary12 Feb, 2026
Executive summary
Achieved key milestones in clinical and preclinical development for tasquinimod in myelofibrosis and multiple myeloma, and laquinimod in inflammatory eye diseases.
Successfully completed a fully guaranteed rights issue of SEK 70 million to fund operations through 2027.
Ongoing collaborations with leading academic institutions in the US and Europe support clinical programs.
Financial highlights
No net sales recorded for 2025; operating loss was SEK 37.6 million, down from SEK 39.8 million in 2024.
Loss after tax for 2025 was SEK 37.3 million, compared to SEK 39.4 million in 2024.
Cash and cash equivalents at year-end were SEK 65.1 million, up from SEK 27.4 million at the end of 2024.
Cash flow from financing activities was SEK 70.1 million, reflecting proceeds from the rights issue.
Equity/assets ratio improved to 79.2% from 75.8% in 2024.
Outlook and guidance
Funding secured to support ongoing clinical studies and business development through 2027.
Interim results from tasquinimod clinical studies expected in 2026, with efficacy results anticipated by end of 2027.
Focus remains on advancing tasquinimod in myelofibrosis and securing partnerships for laquinimod.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Active Biotech earnings date
Q1 20267 May, 2026
Active Biotech
Next Active Biotech earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Active Biotech AB is a Swedish biotechnology company focused on developing treatments for cancer and inflammatory diseases. Its key projects include Tasquinimod, an immunomodulatory molecule in clinical trials for multiple myeloma and myelofibrosis, and Laquinimod, aimed at treating inflammatory eye disorders like uveitis. Additionally, Naptumomab, an antibody-based immunotherapy, is being tested in combination with other treatments for solid tumors, including non-small cell lung cancer. The company is headquartered in Lund, Sweden, and is listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage